Under the microscrope: Neuren Pharmaceuticals - John Pilcher, Chief Executive Officer

from Morgans Under the Microscope · host Morgans Financial Limited

Senior Analyst Scott Power from the Morgans Healthcare team speaks with Jon Pilcher, Chief Executive Officer of Neuren Pharmaceuticals (ASX:NEU). Jon explains a number of key catalysts which are expected in 2021.

Episode metadata supplied by the publisher feed · Published Jan 11, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

Under the microscrope: Neuren Pharmaceuticals - John Pilcher, Chief Executive Officer

0:00 7:00

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Morgans Under the Microscope?

This episode is 7 minutes long.

When was this Morgans Under the Microscope episode published?

This episode was published on January 11, 2021.

Can I download this Morgans Under the Microscope episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!